acetylcysteine has been researched along with cyslabdan in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, A; Kim, YP; Matsumoto, A; Omura, S; Shiomi, K; Takahashi, Y; Tomoda, H | 1 |
| Fukumoto, A; Hanaki, H; Kim, YP; Omura, S; Shiomi, K; Tomoda, H | 1 |
| Tomoda, H | 1 |
| Ikeda, H; Koyama, N; Münch, D; Sahl, HG; Schneider, T; Shibagaki, Y; Tokura, Y; Tomoda, H | 1 |
| Inokoshi, J; Koyama, N; Tomoda, H | 1 |
| Matsumoto, A; Ōmura, S; Takahashi, Y; Také, A | 1 |
| Ikeda, H; Nagamitsu, T; Shin-Ya, K; Tomoda, H | 1 |
| Arima, S; Hishinuma, Y; Ito, F; Kim, YP; Nagamitsu, T; Ohtawa, M; Ōmura, S; Takagi, E; Tomoda, H; Uchida, R; Yamada, T | 1 |
2 review(s) available for acetylcysteine and cyslabdan
| Article | Year |
|---|---|
[Mode of action of microbial anti-MRSA agents].
Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Cross Infection; Diterpenes; Drug Design; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mycotoxins; Spiro Compounds | 2012 |
Anti-infectious agents against MRSA.
Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cell Wall; Diterpenes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycotoxins; Organothiophosphorus Compounds; Peptidoglycan; Spiro Compounds; Teichoic Acids; Vancomycin; Virulence Factors; Xanthophylls | 2012 |
6 other study(ies) available for acetylcysteine and cyslabdan
| Article | Year |
|---|---|
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
Topics: Acetylcysteine; Anti-Bacterial Agents; Diterpenes; Drug Synergism; Fermentation; Humans; Imipenem; Magnetic Resonance Spectroscopy; Methicillin Resistance; Microscopy, Electron, Scanning; Molecular Conformation; Molecular Structure; Staphylococcus aureus; Streptomyces | 2008 |
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
Topics: Acetylcysteine; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Diterpenes; Drug Synergism; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptomyces | 2008 |
The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis.
Topics: Acetylcysteine; Bacterial Proteins; Boron Compounds; Chromatography, High Pressure Liquid; Diterpenes; DNA Primers; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Japan; Methicillin-Resistant Staphylococcus aureus; Penicillins; Peptides; Peptidoglycan; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2012 |
Streptomyces lactacystinicus sp. nov. and Streptomyces cyslabdanicus sp. nov., producing lactacystin and cyslabdan, respectively.
Topics: Acetylcysteine; Anti-Bacterial Agents; Diterpenes; DNA, Bacterial; Gene Expression Regulation, Bacterial; Phylogeny; Species Specificity; Streptomyces | 2015 |
Biosynthesis of mercapturic acid derivative of the labdane-type diterpene, cyslabdan that potentiates imipenem activity against methicillin-resistant Staphylococcus aureus: cyslabdan is generated by mycothiol-mediated xenobiotic detoxification.
Topics: Acetylcysteine; Amidohydrolases; Biosynthetic Pathways; Cysteine; Diterpenes; Glycopeptides; Imipenem; Inactivation, Metabolic; Inositol; Methicillin-Resistant Staphylococcus aureus; Multigene Family; Mycelium; Organophosphates; Streptomyces; Xenobiotics | 2016 |
Synthesis and Structural Revision of Cyslabdan.
Topics: Acetylcysteine; Diterpenes; Molecular Conformation; Streptomyces | 2016 |